12:00 AM
 | 
Feb 11, 2013
 |  BC Week In Review  |  Company News  |  Deals

Orphan Technologies, St. George's University deal

The university granted Orphan Technologies exclusive, worldwide rights to preclinical enzyme replacement therapies (ERTs) OT-15 and OT-81. OT-15, or...

Read the full 81 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >